Global NewBorn Screening Market, by Product (Instruments, and Assay Kits and Reagents),by Test Type (Dry Blood Spot Test, Cardiac Test, Hearing Test, Urine Test, andOthers), by Application (Phenylketonuria (PKU), Maple Syrup Urine DiseaseCritical Congenital Cardiac Disease, Hearing Disability, Sickle Cell Disease,and Others), by End User (Hospitals, Maternity and Specialty Clinics, andDiagnostic Centers), and by Region (North America, Latin America, Europe, AsiaPacific, Middle East, and Africa), is estimated to be valued at US$ 1,412.2 Mnin 2021 and is expected to exhibit a CAGR of 10.5% during the forecast period(2021-2028), as highlighted in a new report published by Coherent MarketInsights.
Increasing government support fornew born screening and development in screening technology are expected todrive the market growth during the forecast period. For instance, New bornFoundation in USA, a global non-profit organization is working in collaborationwith public health and government agencies, healthcare providers andresearchers, international NGOs working in the new born health ecosystem. UnderNew born Foundation, 3.2 million infants have been screened for heart defectsand other health conditions. For instance, in 2013, New born Foundationlaunched BORN project, which impacted 31 provinces and around 400,000 new born,as well as 50 maternal and child health facilities in China.
Global New Born Screening Market–Impact of Coronavirus (COVID-19) Pandemic
The coronavirus or COVID-19outbreak that started from Wuhan, China has spread across continents, affectingvarious industries globally. Supply of raw materials has been severelydisrupted due to the forced quarantine, and lack of labour and raw materials.As the link between regional warehouses is not smooth, the transportation ofraw materials between regions cannot be carried out successfully.
This shortage of raw materialsand components have affected the supply chain of the global new born screeningmarket. Supply chain and manufacturing activities in India, Italy, Spain, U.K.,and the U.S. have been disrupted due to lockdowns implemented by governments inthe past few months, while countries such as Saudi Arabia, UAE, Egypt, andothers are facing problems with regards to transportation of instruments and kitsused for new born screening.
Furthermore, the global new born screeningmarket players are facing major challenges due to the COVID-19 pandemic onvarious fronts. The major challenges include supply of raw materials requiredfor manufacturing instruments and reagent kits due to irregularities intransportation facility.
* The sample copy includes:Report Summary, Table of Contents, Segmentation, Competitive Landscape, ReportStructure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2192
Browse Market Data 43 Tables and40 Figures spread through 288 Pages and in-depth TOC on “Global New BornScreening Market”- Forecast to 2028,Global New Born Screening Market, by Product (Instruments, and Assay Kits andReagents), by Test Type (Dry Blood Spot Test, Cardiac Test, Hearing Test, UrineTest, and Others), by Application (Phenylketonuria, Critical Congenital CardiacDisease, Maple Syrup Urine Disease, Hearing Disability, Sickle Cell Disease,and Others), by End User (Hospitals, Maternity and Specialty Clinics, andDiagnostic Centers), and by Region (North America, Latin America, Europe, AsiaPacific, Middle East, and Africa)
Moreover, high birth rate and increasingrate of neonatal diseases are expected to drive the market growth during theforecast period. Newborn population is one of the most vulnerable grouppopulation for various disease such as epilepsy, polio encephaliphitis, asthma,chronic obstructive pulmonary disease (COPD), and other respiratory disease,leukemia, diarrhea, anemia, and other rare disease that results in substantialeconomic burden. Hence, it is important to conduct new born screening for earlydetection of the diseases.
Key Takeaways of the Global NewBorn Screening Market:
The global new born screeningmarket is expected to grow with a CAGR of 10.5% during the forecast period dueto key players operating in the market are adopting strategies such ascollaborations and acquisitions in order to expand their product portfolio. Forinstance, in November 2020, Natus Medical Inc., a medical device companyacquired Babybe GmbH, a company that develops its patented remote mother tobaby communication technology and soft robotics for neonatal healthcare. Thecompany’s technology will add to Natus Medical Inc.’s Newborn Care portfolio ofproducts.
Among product, instrumentssegment accounted for the highest CAGR in global new born screening marketduring forecast period. For instance, in July 2017, Department of Biotechnology(DBT), Ministry of Science and Technology, (Government of India) launched Sohum– the newborn hearing screening device developed by SIB startup, SohumInnovation Labs India Pvt. Ltd., in India.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/newborn-screening-market-2192
On the basis of test type, dryblood spot test accounted for the largest market share in the global new bornscreening market over the forecast period. For instance, in January 2019,Virginia Department of Health, announced the launch of Virginia New bornScreening Program. The program include education about new born screening andconducting dried-blood spot screening tests, referral, follow-up and diagnosis,dietary and medical management, and treatment in Hospitals of Virginia.
On the basis of application,phenylketonuria (PKU) segment is expected to grow with the fastest growth ratein global new born screening market during forecast period. For instance, in2017, Scientific Center of Obstetrics, Gynecology and Perinatology, RepublicanMedical Genetic Consultation, Almaty, Kazakhstan collaboratively initiated massscreening of Phenylketonuria (PKU) from year 2017 to 2019. They screened around1 million newborns for Phenylketonuria (PKU) globally.
Among the end user, hospitalssegment accounted for the largest share in global new born screening market in2020. For instance, in May 2021, Cure Sanfilippo Foundation, a non –governmentorganization (NGO) announced the initiation of the program called pilot newborn screening for multiple disorders, which includes Sanfilippo syndrome typeA and type B. This program is supported by eight New York hospitals such as theMaimonides Medical Center, in Brooklyn; New York-Presbyterian/ColumbiaUniversity Medical Center, in Manhattan; Mount Sinai Hospital and Mount SinaiWest, and the North Shore University Hospital, and others.
Among the regions, Asia Pacificregion accounted for the largest CAGR in global new born screening market in2021. Increasing programmes by key players for newborn screening expected todrive growth of the Asia Pacific newborn screening market during the forecastperiod.
Major players operating in globalnew born screening market include Agilent Technologies, Inc, Bio-radlaboratories, Inc. Medtronic Plc, Masimo Corporation, Natus Medical Inc.,Perkin Elmer, Inc., ZenTec S.A., Trivitron Healthcare Pvt Ltd, WatersTechnologies Corporation, Danaher Corporation, Baebies, Inc., Parseq Lab Co.Ltd, Chromesystem Instruments and Chemicals GmbH, and RECIPE Chemicals+Instrument GmbH.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2192
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
